000			04152nam a22003973i 4500
001			EBC7113890
003			MiAaPQ
005			20240724115724.0
006			m o d |
007			cr cnu||||||||
008			240724s2022 xx o ||||0 eng d
020			_a9789280533606 _q(electronic bk.)
020			_z9789280533590
035			_a(MiAaPQ)EBC7113890
035			_a(Au-PeEL)EBL7113890
035			_a(OCoLC)1348480949
040			_aMiAaPQ _beng _erda _epn _cMiAaPQ _dMiAaPQ
100	1		_aProperty, World Intellectual.
245	1	0	_aCOVID-19-Related Vaccines and Therapeutics : _bPreliminary Insights on Related Patenting Activity During the Pandemic.
250			_a1st ed.
264		1	_aGeneva : _bWorld Intellectual Property Organization, _c2022.
264		4	_c©2022.
300			_a1 online resource (83 pages)
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
505	0		_aIntro -- _Hlk93048502 -- Acknowledgements -- Key findings -- Introduction -- Background - biology of COVID-19 -- Overview of patenting activity related to COVID-19 -- Patent filings during 2020-2021 -- Filing and publication of COVID-19-related patent applications over time -- COVID-19-related vaccine and therapeutic patent applicant profiles -- Research collaboration and IP strategies related to technologies important to COVID-19 vaccines and therapeutics -- Disclosure of sequences within patent documents -- COVID-19 vaccines -- Background - vaccine platforms -- Conventional vaccine platforms -- Novel vaccine platforms -- Patent and vaccine distribution by vaccine platform and published applicant location -- Speed of vaccine development -- COVID-19 vaccine patent landscape -- Core vaccine technologies, collaboration and licensing -- Analysis of WHO data on COVID-19 vaccines -- Timelines on key technologies for COVID-19 vaccine development -- Technologies relevant to mRNA vaccine -- Timeline details for adenovirus vaccine development -- Timeline details for vaccine adjuvant development -- COVID-19 therapeutics -- Background -- Analysis of COVID-19 therapeutics-related patent applications by substances type -- Top locations of patent applicants for COVID-19 therapeutics and their filing strategies -- Highlights of patent filings related to COVID-19 therapeutic development -- Patent filings related to development of small-molecule drugs for COVID-19 -- Patent filings related to the development of biologics for COVID-19 -- Patents related to antibodies for COVID-19 treatment -- Peptide and protein therapies -- Nucleic-acid-based therapies -- Aptamer-mediated therapy -- Cell-based therapies -- Other biologic-based therapies -- Analysis of COVID-19 therapeutics in clinical trials.
505	8		_aAnalysis of COVID-19 therapeutics data in the Milken Institute and Regulatory Affairs Professionals Society (RAPS) tracker data -- Distribution of COVID-19 drug candidates across small molecules and biologics, repurposed drugs and de novo synthesized drugs -- Classification of COVID-19 drug candidates in clinical trials by molecular nature and function -- Feature summary of examples of anti-COVID-19 drug candidates in clinical trials -- Perspectives -- Annex -- Data sources and methods -- Tables of vaccine types and candidates currently in clinical trials -- Examples of partial, early disclosure observed at the Israeli, U.K. and Singapore patent offices -- Glossary -- References -- Further reading.
588			_aDescription based on publisher supplied metadata and other sources.
590			_aElectronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.
650		0	_aCOVID-19 (Disease).
655		4	_aElectronic books.
776	0	8	_iPrint version: _aProperty, World Intellectual _tCOVID-19-Related Vaccines and Therapeutics _dGeneva : World Intellectual Property Organization,c2022 _z9789280533590
797	2		_aProQuest (Firm)
856	4	0	_uhttps://ebookcentral.proquest.com/lib/orpp/detail.action?docID=7113890 _zClick to View
999			_c33439 _d33439